Rockley Photonics Holdings Ltd (RKLYQ)

[jacksonjohn]

They did not provide a guidance for 2023. They said they will do this in 3qrtr earnings report. They is the fact, you can read that from transcript. They were doing lot of word play during cc.

If they thought it would be more then like all companies they would increase guidance or leave it until they can comfortably increase it.

They need money soon and they are probably running into issues. I’m not sure if it’s in clinical validation or regulatory front. I believe these guys were just overly optimistic and regulatory landscape has changed.